SS
DYN icon

SBI Securities’s Dyne Therapeutics DYN Stock Holding History

SBI Securities’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.88K Buy
159
+9
+6% +$155 ﹤0.01% 2280
2025
Q4 		$2.93K Sell
150
-10
-6% -$189 ﹤0.01% 2245
2025
Q3 		$2.02K Buy
160
+61
+62% +$696 ﹤0.01% 2419
2025
Q2 		$942 Buy
99
+30
+43% +$330 ﹤0.01% 2705
2025
Q1 		$722 Buy
69
+50
+263% +$715 ﹤0.01% 2729
2024
Q4 		$448 Buy
+19
New +$562 ﹤0.01% 2934

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

SBI Securities's DYN Position: Q1 2026 in Review

SBI Securities increased its Dyne Therapeutics (DYN) stake by 6% in Q1 2026, buying an estimated $155 and bringing the position to 159 shares worth $2.88K. The position accounts for ﹤0.01% of the portfolio, ranked #2280.

SBI Securities first reported a position in DYN in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.93K in Q4 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • SBI Securities held 159 shares of Dyne Therapeutics worth $2.88K as of Q1 2026.
  • SBI Securities bought 9 Dyne Therapeutics shares in Q1 2026, an estimated $155.
  • Dyne Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2280 holding.
  • SBI Securities first reported a position in Dyne Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Dyne Therapeutics position peaked at $2.93K in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.